Gilotrif is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Afatinib.
Product ID | 0597-0138_256c019d-6658-43f0-8ec5-2dee75f0e92d |
NDC | 0597-0138 |
Product Type | Human Prescription Drug |
Proprietary Name | Gilotrif |
Generic Name | Afatinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2013-07-12 |
Marketing Category | NDA / NDA |
Application Number | NDA201292 |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | AFATINIB |
Active Ingredient Strength | 40 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2013-08-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA201292 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-08 |
Marketing Category | NDA |
Application Number | NDA201292 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-08-08 |
Ingredient | Strength |
---|---|
AFATINIB | 40 mg/1 |
SPL SET ID: | fd638e5e-8032-e7ca-0179-95e96ab5d387 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0597-0137 | Gilotrif | afatinib |
0597-0138 | Gilotrif | afatinib |
0597-0141 | Gilotrif | afatinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
GILOTRIF 86011486 4470944 Live/Registered |
Boehringer Ingelheim International GmbH 2013-07-16 |